$415 Million is the total value of GREAT POINT PARTNERS LLC's 40 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 71.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XENE | Sell | XENON PHARMACEUTICALS INC | $30,685,000 | -8.7% | 850,000 | -23.0% | 7.39% | -8.3% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $28,657,000 | -3.3% | 215,000 | +13.2% | 6.90% | -2.9% |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $27,526,000 | +67.0% | 3,560,984 | +47.1% | 6.63% | +67.7% |
| ALPN | Buy | ALPINE IMMUNE SCIENCES INC | $24,829,000 | +441.5% | 3,448,521 | +540.0% | 5.98% | +443.5% |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $23,805,000 | +1.2% | 966,108 | -0.5% | 5.73% | +1.6% |
| HRTX | New | HERON THERAPEUTICS INC | $23,484,000 | – | 5,645,161 | +100.0% | 5.66% | – |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $22,515,000 | +49.6% | 1,551,719 | +1.4% | 5.42% | +50.1% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $21,762,000 | +660.4% | 1,041,737 | +191.6% | 5.24% | +663.8% |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $18,880,000 | +42.0% | 510,000 | -27.1% | 4.55% | +42.6% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $16,043,000 | +6.1% | 1,019,282 | -5.9% | 3.86% | +6.5% |
| PCVX | Sell | VAXCYTE INC | $14,400,000 | -32.8% | 600,000 | -39.1% | 3.47% | -32.6% |
| GLPG | Sell | GALAPAGOS NVspon adr | $13,065,000 | -35.0% | 306,411 | -14.9% | 3.15% | -34.7% |
| ABOS | Sell | ACUMEN PHARMACEUTICALS INC | $12,036,000 | +69.0% | 1,200,000 | -20.8% | 2.90% | +69.7% |
| ALKS | Buy | ALKERMES PLC | $11,332,000 | +5.2% | 507,500 | +40.3% | 2.73% | +5.6% |
| SGEN | New | SEAGEN INC | $10,467,000 | – | 76,500 | +100.0% | 2.52% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $10,437,000 | – | 1,050,000 | +100.0% | 2.51% | – |
| Sell | CINCOR PHARMA INC | $9,889,000 | -21.6% | 301,324 | -55.0% | 2.38% | -21.3% | |
| Sell | VENTYX BIOSCIENCES INC | $9,425,000 | +98.0% | 269,967 | -30.6% | 2.27% | +98.7% | |
| TCDA | Sell | TRICIDA INC | $9,118,000 | -19.1% | 870,000 | -25.3% | 2.20% | -18.8% |
| RAPT | New | RAPT THERAPEUTICS INC | $7,579,000 | – | 315,000 | +100.0% | 1.82% | – |
| URGN | UROGEN PHARMA LTD | $7,267,000 | +1.6% | 873,424 | 0.0% | 1.75% | +2.0% | |
| REPL | New | REPLIMUNE GROUP INC | $6,735,000 | – | 390,000 | +100.0% | 1.62% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $6,207,000 | – | 95,500 | +100.0% | 1.50% | – |
| MIST | New | MILESTONE PHARMACEUTICALS IN | $6,200,000 | – | 674,656 | +100.0% | 1.49% | – |
| ETNB | Sell | 89BIO INC | $5,529,000 | +22.6% | 955,000 | -31.8% | 1.33% | +23.1% |
| GBIO | New | GENERATION BIO CO | $4,381,000 | – | 825,077 | +100.0% | 1.06% | – |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $4,137,000 | – | 316,256 | +100.0% | 1.00% | – |
| Buy | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $3,818,000 | +68.3% | 492,000 | +13.9% | 0.92% | +68.9% | |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $3,686,000 | – | 78,527 | +100.0% | 0.89% | – |
| LRMR | New | LARIMAR THERAPEUTICS INC | $3,632,000 | – | 1,135,000 | +100.0% | 0.88% | – |
| DTIL | Sell | PRECISION BIOSCIENCES INC | $3,524,000 | -61.7% | 2,710,805 | -52.9% | 0.85% | -61.6% |
| CBAY | New | CYMABAY THERAPEUTICS INC | $2,798,000 | – | 799,439 | +100.0% | 0.67% | – |
| PIRS | Sell | PIERIS PHARMACEUTICALS INC | $2,260,000 | -51.9% | 1,965,449 | -21.8% | 0.54% | -51.7% |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $1,465,000 | – | 105,000 | +100.0% | 0.35% | – |
| GRCL | New | GRACELL BIOTECHNOLOGIES INCsponsored ads | $1,446,000 | – | 449,049 | +100.0% | 0.35% | – |
| MGTA | Sell | MAGENTA THERAPEUTICS INC | $1,437,000 | +2.4% | 1,019,091 | -12.9% | 0.35% | +2.7% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $1,433,000 | -88.0% | 447,820 | -85.8% | 0.34% | -88.0% |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $1,415,000 | – | 70,621 | +100.0% | 0.34% | – |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $1,315,000 | +4.1% | 2,500,000 | 0.0% | 0.32% | +4.6% | |
| SLN | Sell | SILENCE THERAPEUTICS PLCads | $692,000 | -85.5% | 68,915 | -82.8% | 0.17% | -85.4% |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -336,731 | -100.0% | -1.41% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INCput | $0 | – | -54,900 | -100.0% | -1.67% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -500,000 | -100.0% | -1.74% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -75,000 | -100.0% | -1.75% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -453,118 | -100.0% | -2.21% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -1,204,028 | -100.0% | -2.80% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -193,900 | -100.0% | -3.49% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -149,000 | -100.0% | -4.52% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCput | $0 | – | -150,000 | -100.0% | -5.25% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -610,000 | -100.0% | -5.75% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTNS, INC CMN | 25 | Q3 2019 | 2.5% |
| IOVANCE BIOTHERAPEUTICS, INC. CMN | 16 | Q1 2021 | 14.3% |
| ZOGENIX INC CMN | 16 | Q4 2019 | 8.8% |
| PTC THERAPEUTICS, INC. CMN | 16 | Q3 2023 | 9.9% |
| EXELIXIS, INC | 16 | Q1 2022 | 7.5% |
| SAGE THERAPEUTICS, INC CMN | 15 | Q3 2021 | 10.8% |
| CYTOKINETICS INC | 15 | Q3 2023 | 5.8% |
| ACADIA PHARMACEUTICALS, INC. | 14 | Q1 2021 | 8.8% |
| ACCELERON PHARMA INC CMN | 14 | Q2 2020 | 8.2% |
| CONNECTURE INC | 13 | Q4 2017 | 25.1% |
View GREAT POINT PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 89bio, Inc. | February 14, 2023 | 700,000 | 1.4% |
| KalVista Pharmaceuticals, Inc. | February 14, 2023 | 1,055,801 | 3.1% |
| Avalo Therapeutics, Inc. | February 13, 2023 | 974,639 | 7.1% |
| InflaRx N.V.Sold out | February 14, 2022 | 0 | 0.0% |
| ABEONA THERAPEUTICS INC.Sold out | February 16, 2021 | 0 | 0.0% |
| CONSTELLATION PHARMACEUTICALS INC | February 16, 2021 | 1,024,800 | 2.2% |
| GERON CORP | February 16, 2021 | 12,754,228 | 4.0% |
| Millendo Therapeutics, Inc. | February 16, 2021 | 270,000 | 1.4% |
| NextCure, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | February 16, 2021 | 977,647 | 2.4% |
View GREAT POINT PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View GREAT POINT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.